Related Experiment Videos

Epigenetic control of the immune escape mechanisms in malignant carcinomas

A Francesca Setiadi1, Muriel D David, Robyn P Seipp

  • 1Biomedical Research Centre, Vancouver, British Columbia V6T 1Z3, Canada.

Insights

Epigenetic regulation of the transporter associated with antigen processing 1 (TAP-1) impacts tumor immune evasion. CBP-mediated acetylation controls TAP-1 transcription, offering potential new cancer immunotherapies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Downregulation of transporter associated with antigen processing 1 (TAP-1) is linked to tumor immunoevasion, growth, and metastasis.
  • The molecular mechanisms behind low TAP-1 gene transcription in cancer cells remain largely unexplained.
  • Epigenetic regulation is hypothesized to control tumor antigen processing and immune escape.

Purpose of the Study:

  • To investigate the role of epigenetic regulation in controlling TAP-1 transcription in cancer cells.
  • To elucidate the molecular mechanisms underlying TAP-1 gene downregulation in tumors.
  • To explore potential immunotherapeutic strategies targeting epigenetic modifications.

Main Methods:

  • Assessed recruitment of histone acetyltransferase CBP to the TAP-1 promoter in TAP-deficient cells.
  • Measured histone H3 acetylation levels at the TAP-1 promoter.
  • Investigated the effect of interferon gamma on TAP-1 expression and histone H3 acetylation.

Main Results:

  • Lack of TAP-1 transcription correlated with reduced CBP recruitment and lower histone H3 acetylation at the TAP-1 promoter.
  • Reduced histone H3 acetylation led to decreased accessibility for RNA polymerase II, inhibiting TAP-1 transcription.
  • Interferon gamma was found to upregulate TAP-1 expression by increasing histone H3 acetylation at the TAP-1 promoter locus.

Conclusions:

  • CBP-mediated histone H3 acetylation epigenetically regulates TAP-1 expression by relaxing chromatin structure.
  • Epigenetic modifications at the TAP-1 promoter are crucial for tumor antigen processing and immune escape.
  • Reversing epigenetic dysregulation presents a novel immunotherapeutic approach for cancer treatment.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...